Regulation of reactive oxygen species by p53: Implications for nitric oxide-mediated apoptosis

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 298, Issue 6, 2010, Pages

  Popowich, Daniel A ^a   Vavra, Ashley K ^a   Walsh, Christopher P ^a   Bhikhapurwala, Hussein A ^a   Rossi, Nicholas B ^a   Jiang, Qun ^a   Aalami, Oliver O ^a   Kibbe, Melina R ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Antioxidant proteins; Knockout mouse; Peroxiredoxin 3; Thioredoxin 2; Vascular smooth muscle cell

Indexed keywords

CATALASE; NITRIC OXIDE; PEROXIREDOXIN 3; PROTEIN P53; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; THIOREDOXIN 2;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL LEVEL; CONTROLLED STUDY; MOUSE; MUSCLE CELL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; VASCULAR SMOOTH MUSCLE;

ANIMALS; APOPTOSIS; CELLS, CULTURED; GLUTATHIONE PEROXIDASE; HOMEODOMAIN PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MODELS, ANIMAL; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE; THIOREDOXINS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 77952639876     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00535.2009     Document Type: Article

References (47)

1. Ahanchi SS, Tsihlis ND, Kibbe MR. The role of nitric oxide in the pathophysiology of intimal hyperplasia. J Vasc Surg 45: 64A-73A, 2007.
2. Brown GC. Regulation of mitochondrial respiration by nitric oxide inhibition of cytochrome c oxidase. Biochim Biophys Acta Bioenerget 1504: 46-57, 2001. (Pubitemid 32179657)
3. Brown GC, Borutaite V. Nitric oxide inhibition of mitochondrial respiration and its role in cell death. Free Rad Biol Med 33: 1440-1450, 2002. (Pubitemid 35351587)
4. Brown GC, Borutaite V. Interactions between nitric oxide, oxygen, reactive oxygen species and reactive nitrogen species. Biochem Soc Trans 34: 953-956, 2006. (Pubitemid 44796458)
5. Brune B. Nitric oxide: NO apoptosis or turning it ON?. Cell Death Diff 10: 864-869, 2003.
6. Brune B. The intimate relation between nitric oxide and superoxide in apoptosis and cell survival. Antiox Redox Sig 7: 497-507, 2005. (Pubitemid 40279818)
7. Cadenas E. Nitric oxide, mitochondrial function, and cell signaling (Abstract). Free Rad Res 37: 13, 2003.
8. Cao Z, Lindsay JG, Isaacs NW. Mitochondrial peroxiredoxins. Subcell Biochem 44: 295-315, 2007.
9. Chang TS, Cho CS, Park S, Yu SQ, Kang SW, Rhee SG. Peroxiredoxin III, a mitochondrion-specific peroxidase, regulates apoptotic signaling by mitochondria. J Biol Chem 279: 41975-41984, 2004. (Pubitemid 39313648)
10. Choi BM, Pae HO, Jang SI, Kim YM, Chung HT. Nitric oxide as a pro-apoptotic as well as anti-apoptotic modulator. J Biochem Mol Biol 35: 116-126, 2002. (Pubitemid 35216587)
11. Chung HT, Pae HO, Choi BM, Billiar TR, Kim YM. Nitric oxide as a bioregulator of apoptosis. Biochem Biophys Res Commun 282: 1075-1079, 2001.
12. Ciriolo MR. Redox control of apoptosis. Antiox Redox Sig 7: 432-435, 2005.
13. Cooke JP, Dzau VJ. Nitric oxide synthase: role in the genesis of vascular disease. Ann Rev Med 48: 489-509, 1997. (Pubitemid 27101848)
14. Deshpande NN, Sorescu D, Seshiah P, Ushio-Fukai M, Akers M, Yin QQ, Griendling KK. Mechanism of hydrogen peroxide-induced cell cycle arrest in vascular smooth muscle. Antiox Redox Sig 4: 845-854, 2002. (Pubitemid 35246948)
15. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromocyclic guanosine-monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth-muscle cells. J Clin Invest 83: 1774-1777, 1989. (Pubitemid 19124139)
16. Gordon SA, bou-Jaoude W, Hoffman RA, McCarthy SA, Kim YM, Zhou X, Zhang XR, Simmons RL, Chen Y, Schall L, Ford HR. Nitric oxide induces murine thymocyte apoptosis by oxidative injury and a p53-dependent mechanism. J Leukocyte Biol 70: 87-95, 2001.
17. Gotoh T, Oyadomari S, Mori K, Mori M. Nitric oxide-induced apoptosis in RAW 264.7 macrophages is mediated by endoplasmic reticulum stress pathway involving ATF6 and CHOP. J Biol Chem 277: 12343-12350, 2002. (Pubitemid 34952805)
18. Iwashina M, Shichiri M, Marumo F, Hirata Y. Transfection of inducible nitric oxide synthase gene causes apoptosis in vascular smooth muscle cells. Circulation 98: 1212-1218, 1998. (Pubitemid 28436172)
19. Kapadia MR, Chow LW, Tsihlis ND, Ahanchi SS, Eng JW, Murar J, Martinez J, Popowich DA, Jiang Q, Hrabie JA, Saavedra JE, Keefer LK, Hulvat JF, Stupp SI, Kibbe MR. Nitric oxide and nanotechnology: a novel approach to inhibit neointimal hyperplasia. J Vasc Surg 47: 173-182, 2008.
20. Kawahara K, Oyadomari S, Gotoh T, Kohsaka S, Nakayama H, Mori M. Induction of CHOP and apoptosis by nitric oxide in p53-deficient microglial cells. FEBS Lett 506: 135-139, 2001. (Pubitemid 32925215)
21. -/- vascular smooth muscle cells. Am J Physiol Cell Physiol 282: C625-C634, 2002.
22. Kim YM, Choi BM, Kim YS, Kwon YG, Kibbe MR, Billiar TR, Tzeng E. Protective effect of p53 in vascular smooth muscle cells against nitric oxide-induced apoptosis is mediated by up-regulation of heme oxygenase-2. BMB Rep 41: 164-169, 2008. (Pubitemid 351364770)
23. Kolpakov V, Gordon D, Kulik TJ. Nitric oxide-generating compounds inhibit total protein and collagen-synthesis in cultured vascular smooth-muscle cells. Circ Res 76: 305-309, 1995.
24. Lefer AM. Nitric oxide: nature's naturally occurring leukocyte inhibitor. Circulation 95: 553-554, 1997.
25. Li CQ, Robles AI, Hanigan CL, Hofseth LJ, Trudel LJ, Harris CC, Wogan GN. Apoptotic signaling pathways induced by nitric oxide in human lymphoblastoid cells expressing wild-type or mutant p53. Cancer Res 64: 3022-3029, 2004.
26. Li CQ, Trudel LJ, Wogan GN. Nitric oxide-induced genotoxicity, mitochondrial damage, and apoptosis in human lymphoblastoid cells expressing wild-type and mutant p53. Proc Natl Acad Sci USA 99: 10364-10369, 2002.
27. Li PF, Dietz R, vonHarsdorf R. Differential effect of hydrogen peroxide and superoxide anion on apoptosis and proliferation of vascular smooth muscle cells. Circulation 96: 3602-3609, 1997. (Pubitemid 27513439)
28. Li PF, Dietz R, vonHarsdorf R. Reactive oxygen species induce apoptosis of vascular smooth muscle cell. Febs Lett 404: 249-252, 1997. (Pubitemid 27113462)
29. Maksimovic-Ivanic D, Mijatovic S, Harhaji L, Miljkovic D, Dabideen D, Fan CK, Mangano K, Malaponte G, Al-Abed Y, Libra M, Garotta G, Nicoletti F, Stosic-Grujicic S. Anticancer properties of the novel nitric oxide-donating compound (S,R)-3-phenyl-4,5-dihydro-5-isoxazole acetic acid-nitric oxide in vitro and in vivo. Mol Cancer Ther 7: 510-520, 2008.
30. Mercer J, Figg N, Stoneman V, Braganza D, Bennett MR. Endogenous p53 protects vascular smooth muscle cells from apoptosis and reduces atherosclerosis in ApoE knockout mice. Circ Res 96: 667-674, 2005. (Pubitemid 40478334)
31. Moncada S, Erusalimsky JD. Opinion-Does nitric oxide modulate mitochondrial energy generation and apoptosis? Nat Rev Mol Cell Biol 3: 214-220, 2002. (Pubitemid 37237144)
32. Moncada S, Higgs A. Mechanisms of disease-the L-arginine nitric-oxide pathway. N Engl J Med 329: 2002-2012, 1993.
33. Mooradian DL, Hutsell TC, Keefer LK. Nitric-oxide (No) donor molecules-effect of No release rate on vascular smooth-muscle cell-proliferation in-vitro. J Cardiovasc Pharmacol 25: 674-678, 1995.
34. Mukhopadhyay SS, Leung KS, Hicks MJ, Hastings PJ, Youssoufian H, Plon SE. Defective mitochondrial peroxiredoxin-3 results in sensitivity to oxidative stress in Fanconi anemia. J Cell Biol 175: 225-235, 2006. (Pubitemid 44631417)
35. Nonn L, Berggren M, Powis G. Increased expression of mitochondrial peroxiredoxin-3 (thioredoxin peroxidase-2) protects cancer cells against hypoxia and drug-induced hydrogen peroxide-dependent apoptosis. Mol Cancer Res 1: 682-689, 2003. (Pubitemid 36870521)
36. Pearce CG, Najjar SF, Kapadia MR, Murar J, Eng J, Lyle B, Aalami OO, Jiang Q, Hrabie JA, Saavedra JE, Keefer LK, Kibbe MR. Beneficial effect of a short-acting NO donor for the prevention of neointimal hyperplasia. Free Rad Biol Med 44: 73-81, 2008. (Pubitemid 350138632)
37. Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B. A model for p53-induced apoptosis. Nature 389: 300-305, 1997.
38. Popowich DA, Varu V, Kibbe MR. Nitric oxide: what a vascular surgeon needs to know. Vascular 15: 324-335, 2007. (Pubitemid 350305398)
39. Radomski MW, Palmer RMJ, Moncada S. The role of nitric-oxide and Cgmp in platelet-adhesion to vascular endothelium. Biochem Biophys Res Commun 148: 1482-1489, 1987. (Pubitemid 18074679)
40. Ray JL, Leach R, Herbert JM, Benson M. Isolation of vascular smooth muscle cells from a single murine aorta. Methods Cell Sci 23: 185-188, 2001. (Pubitemid 34863290)
41. Sablina AA, Budanov AV, Ilyinskaya GV, Agapova LS, Kravchenko JE, Chumakov PM. The antioxidant function of the p53 tumor suppressor. Nat Med 11: 1306-1313, 2005. (Pubitemid 41752911)
42. Taimor G, Rakow A, Piper M. Activation of transcription activator protein 1 (AP-1) as an important step in nitric oxide induced apoptosis in adult cardiomyocytes. Circulation 104: 142-143, 2001.
43. Tanner FC, Meier P, Greutert H, Champion C, Nabel EG, Luscher TF. Nitric oxide modulates expression of cell cycle regulatory proteins: a cytostatic strategy for inhibition of human vascular smooth muscle cell proliferation. Circulation 101: 1982-1989, 2000.
44. Tarr JM, Eggleton P, Winyard PG. Nitric oxide and the regulation of apoptosis in tumour cells. Curr Pharm Design 12: 4445-4468, 2006. (Pubitemid 44835156)
45. Tzeng E, Kim YM, Pitt BR, Lizonova A, Kovesdi I, Billiar TR. Adenoviral transfer of the inducible nitric oxide synthase gene blocks endothelial cell apoptosis. Surgery 122: 255-263, 1997. (Pubitemid 27383063)
46. Yetik-Anacak G, Catravas JD. Nitric oxide and the endothelium: history and impact on cardiovascular disease. Vascul Pharmacol 45: 268-276, 2006. (Pubitemid 44765289)
47. Ziche M, Morbidelli L, Masini E, Amerini S, Granger HJ, Maggi CA, Geppetti P, Ledda F. Nitric-oxide mediates angiogenesis in-vivo and endothelial-cell growth and migration in-vitro promoted by substance-P. J Clin Invest 94: 2036-2044, 1994.